PAQR7 and lung adenocarcinoma: In vivo studies revealed that progesterone can inhibit cell growth in lung adenocarcinoma via membrane progesterone receptor alpha (mPRα), with higher levels of mPRα expression correlating with worse prognosis and downregulation of mPRα, leading to inhibition of lung adenocarcinoma proliferation [161].